Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical Guardrails for Hybrid-Controlled Trials: Robust to Confounding and Between-Study Heterogeneity.

Therapeutic innovation & regulatory science·2026
Same author

Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?

PharmacoEconomics·2025
Same author

A Response to the Letter to the Editor: "Decision Trees and Random Forests: Nonlinear and Nonparametric Alternatives to Logistic Regression in Biological Data Analysis".

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Evaluation of Optimal Cut-Offs and Dichotomous Combinations for Two Biomarkers to Improve Patient Selection.

Therapeutic innovation & regulatory science·2025
Same author

Worldwide Incidence and Mortality of Biliary Tract Cancer.

Gastro hep advances·2024
Same author

Biomarker-Driven Oncology Trial Design and Subgroup Characterization: Challenges and Potential Solutions.

JCO precision oncology·2024

Related Experiment Video

Updated: Jun 16, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Approximating the risk score for disease diagnosis using MARS.

Binbing Yu1

  • 1Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, Bethesda, Maryland 20892, U.S.A.

Journal of Applied Statistics
|February 18, 2010
PubMed
Summary

Multivariate adaptive regression splines (MARS) effectively approximate risk scores for disease diagnosis using multiple markers. This method provides a complete ROC curve across all false-positive rates, improving diagnostic accuracy.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Related Experiment Videos

Last Updated: Jun 16, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Area of Science:

  • Biostatistics
  • Medical Diagnostics
  • Machine Learning in Healthcare

Background:

  • Accurate disease diagnosis often relies on combining multiple diagnostic markers.
  • Previous methods for risk score approximation, like McIntosh and Pepe's, have limitations in ROC curve range and require prior information.
  • Diagnostic tests are imperfect, and single markers rarely outperform others uniformly.

Purpose of the Study:

  • To evaluate Multivariate Adaptive Regression Splines (MARS) as a tool for approximating risk scores in disease diagnosis.
  • To address limitations of existing methods, particularly concerning the range of Receiver Operating Characteristic (ROC) curves.
  • To provide an easily implementable and interpretable method for combining multiple diagnostic markers.

Main Methods:

  • Utilized Multivariate Adaptive Regression Splines (MARS) to approximate the risk score, which is the probability of disease conditional on multiple markers.
  • Employed simulation studies to assess the performance of MARS.
  • Compared MARS with existing two-step procedures for risk score approximation.

Main Results:

  • MARS successfully approximates risk scores when combining multiple markers, especially when ROC curves from different tests cross.
  • The MARS-derived ROC curve is defined across the entire range of false-positive rates (0,1), overcoming limitations of prior methods.
  • The MARS approach is shown to be easy to implement and offers intuitive interpretation.

Conclusions:

  • MARS is a valuable tool for disease screening and diagnosis by effectively combining multiple markers.
  • The MARS method enhances diagnostic accuracy and provides a complete ROC curve without needing extra prior information.
  • This approach offers practical advantages in implementation and interpretability for clinical applications.